Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world
Neuralink Corp., Elon Musk’s brain implant company, plans to launch a clinical trial in the US in October aiming to use its device to translate thoughts into text, potentially opening up new possibilities for speech-impaired people to communicate.
The company also hopes to put its device in a healthy person by 2030, as Neuralink moves toward an eventual goal of creating consumer technology. It would be a massive expansion from the current activities of brain implant companies, which are testing devices only in people with severe medical conditions that make a risky brain surgery worthwhile.